Stay updated with breaking news from Patrickr Oneil. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) has earned an average recommendation of “Hold” from the ten research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the company. The average […]
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) have been given an average rating of “Hold” by the ten analysts that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating on the […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) shares gapped down prior to trading on Wednesday . The stock had previously closed at $43.33, but opened at $40.49. Ionis Pharmaceuticals shares last traded at $41.18, with a volume of 334,112 shares changing hands. Wall Street Analyst Weigh In A number of research firms have recently commented […]
Nikko Asset Management Americas Inc. decreased its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 23.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 336,732 shares of the company’s stock after selling 100,444 shares during the quarter. Nikko […]
Nikko Asset Management Americas Inc. lessened its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 23.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 336,732 shares of the company’s stock after selling 100,444 shares during […]